Bioprinting technique creates thick 3D tissues composed of human stem cells and embedded vasculature, with potential applications in drug testing and regenerative medicine
A team at the Wyss Institute for Biologically Inspired Engineering at Harvard University and the Harvard John A. Paulson School for Engineering and Applied Sciences (SEAS) has invented a method for 3D bioprinting thick vascularized tissue constructs composed of human stem cells, extracellular matrix, and circulatory channels lined with endothelial blood vessel cells. The resulting network of vasculature contained within these deep tissues enables fluids, nutrients and cell growth factors to be controllably perfused uniformly throughout the tissue. The advance is reported March 7 in the journal Proceedings of the National Academy of Sciences.
“This latest work extends the capabilities of our multi-material bioprinting platform to thick human tissues, bringing us one step closer to creating architectures for tissue repair and regeneration,” says Wyss Core Faculty member Jennifer A. Lewis, Sc.D., senior author on the study, who is also the Hansörg Wyss Professor of Biologically Inspired Engineering at SEAS.
To date, scaling up human tissues built of a variety of cell types has been limited by a lack of robust methods for embedding life-sustaining vascular networks. Building on their earlier work, Lewis and her team have now increased the tissue thickness threshold by nearly tenfold, setting the stage for future advances in tissue engineering and repair. The method combines vascular plumbing with living cells and an extracellular matrix, enabling the structures to function as living tissues. In the study, Lewis and her team showed that their 3D bioprinted tissues could sustain and function as living tissue architectures for upwards of six weeks.
In the study, Lewis’ team demonstrated the 3D printing of one centimeter-thick tissue containing human bone marrow stem cells surrounded by connective tissue. By pumping bone growth factors through the supporting vasculature lined with the same endothelial cells found in our blood vessels, the team induced cell development toward bone cells over the course of one month.
“This research will help to establish the fundamental scientific understanding required for bioprinting of vascularized living tissues,” Zhijian Pei, National Science Foundation Program Director for the Directorate for Engineering Division of Civil, Mechanical and Manufacturing Innovation, which funded the project. “Research such as this enables broader use of 3-D human tissues for drug safety and toxicity screening and, ultimately, for tissue repair and regeneration.”
Learn more: Scaling up tissue engineering
The Latest on: Bioprinting
via Google News
The Latest on: Bioprinting
- 3D Bioprinting Market Share, Upcoming Trends, Size, Key Segments, Growth Status And Forecast 2031on May 13, 2022 at 12:43 am
Kenneth Research recently added a report on 3D Bioprinting Market in its database of market research reports which provides its readers an in-depth analysis on the latest trends, growth ...
- Mount Sinai adds 3D bioprinting platform to its innovation incubatoron May 10, 2022 at 11:17 am
New York City-based Mount Sinai added an on-demand 3D-bioprinting platform, called Adam, to its virtual incubator program. Adam has been accepted to Mount Sinai's Elementa Labs as a member of its 2022 ...
- Global 3D Bioprinting Market - Size By Type, By Distribution Channel, And Forecast Till 2022-2031on May 10, 2022 at 5:43 am
Shibuya-ku, Tokyo, Japan, Japan, May 10, 2022, 08:27 /Comserve / -- Global 3D Bioprinting Market - Share & Industry Analysis Reports, Global Forecast till 2022-2031 Global 3D Bioprinting Market ...
- A.D.A.M. Bioprinting Will Cooperate with a Large Hospital System in USon May 10, 2022 at 5:06 am
A.D.A.M. has announced its acceptance and entrance into Elementa Labs, the virtual incubator program of the Mount Sinai Health System in New York, NY, as a member of its 2022 cohort.
- New Bioprinting Technique to Make Artificial Cartilage Implantson May 9, 2022 at 5:00 pm
Researchers at the University of Alberta have developed a method to 3D print cartilage-like materials consisting of a collagen hydrogel containing human chondrocytes. The printed structures mimic ...
- 3D Bioprinting Market Outlook: Big Things are Happeningon May 9, 2022 at 6:06 am
3D Bioprinting Market business research report assesses the current as well as upcoming performance of the market, and also brand-new trends in the market. It provides product overview and ...
- 3D-Bioprinting Platform Developed to Treat Patients with Muscle, Tendon Diseaseson May 8, 2022 at 5:00 pm
Researchers in Switzerland have advanced the use of 3D bioprinting for the treatment of degenerative muscle and tendon diseases with a new platform, which will advance the production of viable printed ...
- 3D Bioprinting in Medical Market Growth, Global Industry Share, Trends, Size, Top Leaders, Future Plans and Opportunity Assessment (2022-2028)on May 3, 2022 at 11:27 pm
Global 3D Bioprinting in Medical Market (2022) presents company profiling, regions, revenue, size, share, recent trends, business prospect, by services. It includes market overvie ...
- FRESH Takes Bioprinting to the Next Levelon May 3, 2022 at 5:00 pm
Researchers are taking steps forward to advance an approach to 3D bioprinting that scientists think one day has the potential to facilitate the fabrication of entire human organs. Scientists at ...
via Bing News